1.
Papp K, Paul C, Kleyn CE, Huang Y-H, Tsai T-F, Schuster C, El Baou C, Toth A, Riedl E, Mrowietz U. Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis. Acta Derm Venereol [Internet]. 2022 Mar. 15 [cited 2024 Apr. 19];102:adv00672. Available from: https://medicaljournalssweden.se/actadv/article/view/1984